Sitagliptin is an oral medication used to treat type 2 diabetes by regulating blood sugar levels. However, during the production process, impurities can form, which may affect the quality and efficacy of the drug. These impurities can be harmful to patients and need to be monitored and controlled to ensure the safety and effectiveness of the medication. Regulatory bodies have strict guidelines in place for the acceptable levels of impurities in pharmaceutical products.